 | • レポートコード：MRC2312MG08143 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の血液培養病理検査市場規模と予測を収録しています。・世界の血液培養病理検査市場：売上、2018年-2023年、2024年-2029年 ・世界の血液培養病理検査市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の血液培養病理検査市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「器具」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 血液培養病理検査のグローバル主要企業は、Biobase Biotech、 Scenker Biological Technology、 Bulldog Bio、 Anaerobe Systems、 Himedia Laboratories、 Autobio Diagnostics、 Axiom Laboratories、 Iridica、 Biosystems、 BINDER GmBH、 Terumo Corporation、 BD、 BioMérieux、 Thermo Fisher Scientific、 Danaher、 Luminex、 Bruker、 Roche、 Mikroscan Technologies、 Labotronics、 Hardy Diagnostics、 OpGen、 Meditech Technologieなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、血液培養病理検査のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の血液培養病理検査市場：タイプ別、2018年-2023年、2024年-2029年 世界の血液培養病理検査市場：タイプ別市場シェア、2022年 ・器具、消耗品、その他 世界の血液培養病理検査市場：用途別、2018年-2023年、2024年-2029年 世界の血液培養病理検査市場：用途別市場シェア、2022年 ・菌血症、真菌血症、抗酸菌検出 世界の血液培養病理検査市場：地域・国別、2018年-2023年、2024年-2029年 世界の血液培養病理検査市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における血液培養病理検査のグローバル売上、2018年-2023年 ・主要企業における血液培養病理検査のグローバル売上シェア、2022年 ・主要企業における血液培養病理検査のグローバル販売量、2018年-2023年 ・主要企業における血液培養病理検査のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Biobase Biotech、 Scenker Biological Technology、 Bulldog Bio、 Anaerobe Systems、 Himedia Laboratories、 Autobio Diagnostics、 Axiom Laboratories、 Iridica、 Biosystems、 BINDER GmBH、 Terumo Corporation、 BD、 BioMérieux、 Thermo Fisher Scientific、 Danaher、 Luminex、 Bruker、 Roche、 Mikroscan Technologies、 Labotronics、 Hardy Diagnostics、 OpGen、 Meditech Technologie ************************************************************* ・調査・分析レポートの概要 血液培養病理検査市場の定義 市場セグメント 世界の血液培養病理検査市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の血液培養病理検査市場規模 世界の血液培養病理検査市場規模：2022年 VS 2029年 世界の血液培養病理検査市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの血液培養病理検査の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の血液培養病理検査製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：器具、消耗品、その他 血液培養病理検査のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：菌血症、真菌血症、抗酸菌検出 血液培養病理検査の用途別グローバル売上・予測 ・地域別市場分析 地域別血液培養病理検査市場規模 2022年と2029年 地域別血液培養病理検査売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Biobase Biotech、 Scenker Biological Technology、 Bulldog Bio、 Anaerobe Systems、 Himedia Laboratories、 Autobio Diagnostics、 Axiom Laboratories、 Iridica、 Biosystems、 BINDER GmBH、 Terumo Corporation、 BD、 BioMérieux、 Thermo Fisher Scientific、 Danaher、 Luminex、 Bruker、 Roche、 Mikroscan Technologies、 Labotronics、 Hardy Diagnostics、 OpGen、 Meditech Technologie ... |
This research report provides a comprehensive analysis of the Blood Culture Pathology Tests market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Blood Culture Pathology Tests market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Blood Culture Pathology Tests, challenges faced by the industry, and potential opportunities for market players.
The global Blood Culture Pathology Tests market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Blood Culture Pathology Tests market presents opportunities for various stakeholders, including Bacteremia, Fungemia. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Blood Culture Pathology Tests market. Additionally, the growing consumer demand present avenues for market expansion.
The global Blood Culture Pathology Tests market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Blood Culture Pathology Tests market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Blood Culture Pathology Tests market.
Market Overview: The report provides a comprehensive overview of the Blood Culture Pathology Tests market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Instruments, Consumables）, region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Blood Culture Pathology Tests market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Blood Culture Pathology Tests market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Blood Culture Pathology Tests market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Blood Culture Pathology Tests market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Blood Culture Pathology Tests market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Blood Culture Pathology Tests market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Blood Culture Pathology Tests, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Blood Culture Pathology Tests market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Blood Culture Pathology Tests market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Instruments
Consumables
Others
Market segment by Application
Bacteremia
Fungemia
Mycobacterial Detection
Global Blood Culture Pathology Tests Market Segment Percentages, By Region and Country, 2022 (%）
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Biobase Biotech
Scenker Biological Technology
Bulldog Bio
Anaerobe Systems
Himedia Laboratories
Autobio Diagnostics
Axiom Laboratories
Iridica
Biosystems
BINDER GmBH
Terumo Corporation
BD
BioMérieux
Thermo Fisher Scientific
Danaher
Luminex
Bruker
Roche
Mikroscan Technologies
Labotronics
Hardy Diagnostics
OpGen
Meditech Technologie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood Culture Pathology Tests, market overview.
Chapter 2: Global Blood Culture Pathology Tests market size in revenue.
Chapter 3: Detailed analysis of Blood Culture Pathology Tests company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood Culture Pathology Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Blood Culture Pathology Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Culture Pathology Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Culture Pathology Tests Overall Market Size
2.1 Global Blood Culture Pathology Tests Market Size: 2022 VS 2029
2.2 Global Blood Culture Pathology Tests Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Blood Culture Pathology Tests Players in Global Market
3.2 Top Global Blood Culture Pathology Tests Companies Ranked by Revenue
3.3 Global Blood Culture Pathology Tests Revenue by Companies
3.4 Top 3 and Top 5 Blood Culture Pathology Tests Companies in Global Market, by Revenue in 2022
3.5 Global Companies Blood Culture Pathology Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Blood Culture Pathology Tests Players in Global Market
3.6.1 List of Global Tier 1 Blood Culture Pathology Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 Blood Culture Pathology Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Blood Culture Pathology Tests Market Size Markets, 2022 & 2029
4.1.2 Instruments
4.1.3 Consumables
4.1.4 Others
4.2 By Type – Global Blood Culture Pathology Tests Revenue & Forecasts
4.2.1 By Type – Global Blood Culture Pathology Tests Revenue, 2018-2023
4.2.2 By Type – Global Blood Culture Pathology Tests Revenue, 2024-2029
4.2.3 By Type – Global Blood Culture Pathology Tests Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Blood Culture Pathology Tests Market Size, 2022 & 2029
5.1.2 Bacteremia
5.1.3 Fungemia
5.1.4 Mycobacterial Detection
5.2 By Application – Global Blood Culture Pathology Tests Revenue & Forecasts
5.2.1 By Application – Global Blood Culture Pathology Tests Revenue, 2018-2023
5.2.2 By Application – Global Blood Culture Pathology Tests Revenue, 2024-2029
5.2.3 By Application – Global Blood Culture Pathology Tests Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Blood Culture Pathology Tests Market Size, 2022 & 2029
6.2 By Region – Global Blood Culture Pathology Tests Revenue & Forecasts
6.2.1 By Region – Global Blood Culture Pathology Tests Revenue, 2018-2023
6.2.2 By Region – Global Blood Culture Pathology Tests Revenue, 2024-2029
6.2.3 By Region – Global Blood Culture Pathology Tests Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Blood Culture Pathology Tests Revenue, 2018-2029
6.3.2 US Blood Culture Pathology Tests Market Size, 2018-2029
6.3.3 Canada Blood Culture Pathology Tests Market Size, 2018-2029
6.3.4 Mexico Blood Culture Pathology Tests Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Blood Culture Pathology Tests Revenue, 2018-2029
6.4.2 Germany Blood Culture Pathology Tests Market Size, 2018-2029
6.4.3 France Blood Culture Pathology Tests Market Size, 2018-2029
6.4.4 U.K. Blood Culture Pathology Tests Market Size, 2018-2029
6.4.5 Italy Blood Culture Pathology Tests Market Size, 2018-2029
6.4.6 Russia Blood Culture Pathology Tests Market Size, 2018-2029
6.4.7 Nordic Countries Blood Culture Pathology Tests Market Size, 2018-2029
6.4.8 Benelux Blood Culture Pathology Tests Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Blood Culture Pathology Tests Revenue, 2018-2029
6.5.2 China Blood Culture Pathology Tests Market Size, 2018-2029
6.5.3 Japan Blood Culture Pathology Tests Market Size, 2018-2029
6.5.4 South Korea Blood Culture Pathology Tests Market Size, 2018-2029
6.5.5 Southeast Asia Blood Culture Pathology Tests Market Size, 2018-2029
6.5.6 India Blood Culture Pathology Tests Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Blood Culture Pathology Tests Revenue, 2018-2029
6.6.2 Brazil Blood Culture Pathology Tests Market Size, 2018-2029
6.6.3 Argentina Blood Culture Pathology Tests Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Blood Culture Pathology Tests Revenue, 2018-2029
6.7.2 Turkey Blood Culture Pathology Tests Market Size, 2018-2029
6.7.3 Israel Blood Culture Pathology Tests Market Size, 2018-2029
6.7.4 Saudi Arabia Blood Culture Pathology Tests Market Size, 2018-2029
6.7.5 UAE Blood Culture Pathology Tests Market Size, 2018-2029
7 Blood Culture Pathology Tests Companies Profiles
7.1 Biobase Biotech
7.1.1 Biobase Biotech Company Summary
7.1.2 Biobase Biotech Business Overview
7.1.3 Biobase Biotech Blood Culture Pathology Tests Major Product Offerings
7.1.4 Biobase Biotech Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.1.5 Biobase Biotech Key News & Latest Developments
7.2 Scenker Biological Technology
7.2.1 Scenker Biological Technology Company Summary
7.2.2 Scenker Biological Technology Business Overview
7.2.3 Scenker Biological Technology Blood Culture Pathology Tests Major Product Offerings
7.2.4 Scenker Biological Technology Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.2.5 Scenker Biological Technology Key News & Latest Developments
7.3 Bulldog Bio
7.3.1 Bulldog Bio Company Summary
7.3.2 Bulldog Bio Business Overview
7.3.3 Bulldog Bio Blood Culture Pathology Tests Major Product Offerings
7.3.4 Bulldog Bio Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.3.5 Bulldog Bio Key News & Latest Developments
7.4 Anaerobe Systems
7.4.1 Anaerobe Systems Company Summary
7.4.2 Anaerobe Systems Business Overview
7.4.3 Anaerobe Systems Blood Culture Pathology Tests Major Product Offerings
7.4.4 Anaerobe Systems Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.4.5 Anaerobe Systems Key News & Latest Developments
7.5 Himedia Laboratories
7.5.1 Himedia Laboratories Company Summary
7.5.2 Himedia Laboratories Business Overview
7.5.3 Himedia Laboratories Blood Culture Pathology Tests Major Product Offerings
7.5.4 Himedia Laboratories Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.5.5 Himedia Laboratories Key News & Latest Developments
7.6 Autobio Diagnostics
7.6.1 Autobio Diagnostics Company Summary
7.6.2 Autobio Diagnostics Business Overview
7.6.3 Autobio Diagnostics Blood Culture Pathology Tests Major Product Offerings
7.6.4 Autobio Diagnostics Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.6.5 Autobio Diagnostics Key News & Latest Developments
7.7 Axiom Laboratories
7.7.1 Axiom Laboratories Company Summary
7.7.2 Axiom Laboratories Business Overview
7.7.3 Axiom Laboratories Blood Culture Pathology Tests Major Product Offerings
7.7.4 Axiom Laboratories Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.7.5 Axiom Laboratories Key News & Latest Developments
7.8 Iridica
7.8.1 Iridica Company Summary
7.8.2 Iridica Business Overview
7.8.3 Iridica Blood Culture Pathology Tests Major Product Offerings
7.8.4 Iridica Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.8.5 Iridica Key News & Latest Developments
7.9 Biosystems
7.9.1 Biosystems Company Summary
7.9.2 Biosystems Business Overview
7.9.3 Biosystems Blood Culture Pathology Tests Major Product Offerings
7.9.4 Biosystems Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.9.5 Biosystems Key News & Latest Developments
7.10 BINDER GmBH
7.10.1 BINDER GmBH Company Summary
7.10.2 BINDER GmBH Business Overview
7.10.3 BINDER GmBH Blood Culture Pathology Tests Major Product Offerings
7.10.4 BINDER GmBH Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.10.5 BINDER GmBH Key News & Latest Developments
7.11 Terumo Corporation
7.11.1 Terumo Corporation Company Summary
7.11.2 Terumo Corporation Business Overview
7.11.3 Terumo Corporation Blood Culture Pathology Tests Major Product Offerings
7.11.4 Terumo Corporation Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.11.5 Terumo Corporation Key News & Latest Developments
7.12 BD
7.12.1 BD Company Summary
7.12.2 BD Business Overview
7.12.3 BD Blood Culture Pathology Tests Major Product Offerings
7.12.4 BD Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.12.5 BD Key News & Latest Developments
7.13 BioMérieux
7.13.1 BioMérieux Company Summary
7.13.2 BioMérieux Business Overview
7.13.3 BioMérieux Blood Culture Pathology Tests Major Product Offerings
7.13.4 BioMérieux Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.13.5 BioMérieux Key News & Latest Developments
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Company Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Blood Culture Pathology Tests Major Product Offerings
7.14.4 Thermo Fisher Scientific Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.14.5 Thermo Fisher Scientific Key News & Latest Developments
7.15 Danaher
7.15.1 Danaher Company Summary
7.15.2 Danaher Business Overview
7.15.3 Danaher Blood Culture Pathology Tests Major Product Offerings
7.15.4 Danaher Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.15.5 Danaher Key News & Latest Developments
7.16 Luminex
7.16.1 Luminex Company Summary
7.16.2 Luminex Business Overview
7.16.3 Luminex Blood Culture Pathology Tests Major Product Offerings
7.16.4 Luminex Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.16.5 Luminex Key News & Latest Developments
7.17 Bruker
7.17.1 Bruker Company Summary
7.17.2 Bruker Business Overview
7.17.3 Bruker Blood Culture Pathology Tests Major Product Offerings
7.17.4 Bruker Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.17.5 Bruker Key News & Latest Developments
7.18 Roche
7.18.1 Roche Company Summary
7.18.2 Roche Business Overview
7.18.3 Roche Blood Culture Pathology Tests Major Product Offerings
7.18.4 Roche Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.18.5 Roche Key News & Latest Developments
7.19 Mikroscan Technologies
7.19.1 Mikroscan Technologies Company Summary
7.19.2 Mikroscan Technologies Business Overview
7.19.3 Mikroscan Technologies Blood Culture Pathology Tests Major Product Offerings
7.19.4 Mikroscan Technologies Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.19.5 Mikroscan Technologies Key News & Latest Developments
7.20 Labotronics
7.20.1 Labotronics Company Summary
7.20.2 Labotronics Business Overview
7.20.3 Labotronics Blood Culture Pathology Tests Major Product Offerings
7.20.4 Labotronics Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.20.5 Labotronics Key News & Latest Developments
7.21 Hardy Diagnostics
7.21.1 Hardy Diagnostics Company Summary
7.21.2 Hardy Diagnostics Business Overview
7.21.3 Hardy Diagnostics Blood Culture Pathology Tests Major Product Offerings
7.21.4 Hardy Diagnostics Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.21.5 Hardy Diagnostics Key News & Latest Developments
7.22 OpGen
7.22.1 OpGen Company Summary
7.22.2 OpGen Business Overview
7.22.3 OpGen Blood Culture Pathology Tests Major Product Offerings
7.22.4 OpGen Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.22.5 OpGen Key News & Latest Developments
7.23 Meditech Technologie
7.23.1 Meditech Technologie Company Summary
7.23.2 Meditech Technologie Business Overview
7.23.3 Meditech Technologie Blood Culture Pathology Tests Major Product Offerings
7.23.4 Meditech Technologie Blood Culture Pathology Tests Revenue in Global Market (2018-2023）
7.23.5 Meditech Technologie Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer